Skip to content

Mettler-Toledo International

US · MTD #673 by market cap Listed 1970
1,533.48 +0.41 +0.03%
Live - 5344 symbols - heartbeat 20s ago · 2026-10-07 19:54
After-hours 1,533.48 0.00%
Market cap
30.73B
P/B
2,396.06
EPS
42.05
Reader sentiment Are you bullish or bearish on MTD?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Fair Value how this is computed

Near fair value
1,238.54 fair value ≈ 1,479.23 1,719.93
  • Implied fair-value range of 1,238.54-1,719.93, from this stock's own trailing 5-year average P/E applied to trailing EPS.
  • Current price is +3.7% above the average-multiple fair value of 1,479.23.

Valuation each multiple against its own 5-year range

P/B ratio 2,360.86 Expensive vs history 94th percentile
5-year average 139.85 · #40 of 40 in Diagnostics & Research
P/E ratio 34.06 In line with history 48th percentile
5-year average 35.18 · forward 31.24 · #10 of 19 in Diagnostics & Research
P/S ratio 7.32 In line with history 54th percentile
5-year average 7.35 · forward 6.99 · #30 of 43 in Diagnostics & Research

Vs. peers Diagnostics & Research

Company Market cap P/E (TTM) P/B Div yield
Mettler-Toledo International (MTD) 30.73B 34.57 2,396.06 0.00%
Thermo Fisher Scientific (TMO) 244.79B 35.63 4.65 0.27%
Danaher (DHR) 153.60B 38.81 2.92 0.66%
Natera (NTRA) 57.02B -293.01 31.30 0.00%
Agilent Technologies (A) 47.67B 33.35 6.47 0.60%
Waters (WAT) 42.84B 110.38 2.82 0.00%

Other StockVane-tracked companies in the same industry.

Morningstar

★★☆☆☆ Fair value1,356.05 Economic moatNarrow UncertaintyHigh

Trading 11.6% above Morningstar's fair value estimate.

Fair value

Mettler-Toledo International Inc is assigned a 2-star quantitative star rating, illustrating our stance that this share class is a somewhat unattractive choice, and investors should look elsewhere for more fruitful opportunities. The stock currently trades at a 11% premium over our quantitative fair value estimate of $1356.05 per share; however, this estimate should be taken with a pinch of salt due to its high uncertainty rating.

The firm's valuation metrics undermine our estimated fair value. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. Reflecting the firm's valuation is its enterprise value to EBITDA ratio of 24.1, which lies in the top 30% compared with global peers. This suggests that the value of its enterprise value, or the value of its shares and debt, is a high multiple of the generated EBITDA. We believe this is a sign that shares could be expensive.

The firm's lack of profitability is an additional cause for concern. Companies with low profitability are often less resilient in recessions and are likely to generate weaker future cash flows for shareholders. The firm's earnings yield of 3.0%, for example, falls in the bottom 45% compared with peers globally. The earnings generated by the company relative to its share price is concerning, which further promotes our unfavorable price/fair value ratio.

Economic moat

The company's narrow economic moat rating suggests it should be able to maintain robust profitability for a decade or longer before competition erodes its advantage. In addition, the company's moderate financial health score is decent and doesn't seriously concern us with regard to financial distress.

By Quantitative Equity Report

Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.